Cette distinction rev\u00eat une importance particuli\u00e8re lorsqu'un cabinet m\u00e9dical \u00e9value un syst\u00e8me de th\u00e9rapie au laser des tissus profonds pour traiter l'arthrose chronique du genou, les troubles tendineux, les douleurs \u00e0 l'\u00e9paule ou d'autres pathologies dans lesquelles la cible pathologique se situe \u00e0 plusieurs centim\u00e8tres sous la surface de traitement.<\/p>\n\n\n\n
Le LaserMedix-MAX de FotonMedix est con\u00e7u pour ce type de protocole de r\u00e9\u00e9ducation \u00e0 haute \u00e9nergie. Il combine des longueurs d\u2019onde de 650 nm, 810 nm, 915 nm, 940 nm et 980 nm, avec une puissance de sortie annonc\u00e9e de 30 W, un indicateur de temp\u00e9rature, une double fonction chaud\/froid et une profondeur de p\u00e9n\u00e9tration annonc\u00e9e pouvant atteindre 15 cm.<\/p>\n\n\n\n
La v\u00e9ritable limite, ce n'est pas la peau<\/h2>\n\n\n\n
Lorsque les cliniciens parlent de p\u00e9n\u00e9tration, on pourrait facilement imaginer qu'un laser se propage simplement vers le bas jusqu'\u00e0 atteindre une profondeur donn\u00e9e.<\/p>\n\n\n\n
Les tissus biologiques ne se comportent pas ainsi.<\/p>\n\n\n\n
Chaque couche modifie l'environnement optique.<\/p>\n\n\n\n
La peau contient de la m\u00e9lanine, du sang et de l'eau. La graisse sous-cutan\u00e9e modifie la diffusion. Le fascia et les muscles poss\u00e8dent leurs propres caract\u00e9ristiques d'absorption et de diffusion. Les vaisseaux sanguins apportent de l'h\u00e9moglobine, qui constitue un chromophore important. Les capsules articulaires et le tissu synovial constituent des structures suppl\u00e9mentaires riches en eau.<\/p>\n\n\n\n
L'\u00e9nergie optique initiale diminue donc progressivement \u00e0 mesure que le faisceau se propage.<\/p>\n\n\n\n
Deux ph\u00e9nom\u00e8nes sont \u00e0 l'origine de ce d\u00e9clin.<\/p>\n\n\n\n
Absorption<\/strong> prive le faisceau en propagation de son \u00e9nergie photonique en la transf\u00e9rant vers les chromophores des tissus.<\/p>\n\n\n\n Diffusion<\/strong> modifie la direction des photons, de sorte que l'\u00e9nergie se r\u00e9partit dans l'espace au lieu de rester concentr\u00e9e le long du trajet optique d'origine.<\/p>\n\n\n\n Cela signifie qu'une t\u00eate de traitement d\u00e9livrant une puissance de cr\u00eate \u00e9lev\u00e9e au niveau de la peau ne garantit pas que la m\u00eame densit\u00e9 de puissance soit pr\u00e9sente au niveau de la capsule articulaire.<\/p>\n\n\n\n C'est la raison pour laquelle un protocole s\u00e9rieux de th\u00e9rapie au laser des tissus profonds doit prendre en compte l'ensemble du trajet optique.<\/p>\n\n\n\n La longueur d'onde de 1 470 nm pr\u00e9sente un int\u00e9r\u00eat particulier, car l'eau l'absorbe bien plus fortement que de nombreuses longueurs d'onde plus courtes du proche infrarouge.<\/p>\n\n\n\n Les donn\u00e9es optiques publi\u00e9es montrent une diff\u00e9rence importante d'absorption de l'eau entre 980 nm et 1 470 nm. Une \u00e9tude consacr\u00e9e \u00e0 l'interaction entre les tissus et les lasers du proche infrarouge fait \u00e9tat d'un coefficient d'absorption de l'eau d'environ 24,8 cm\u207b\u00b9 \u00e0 1 470 nm, contre environ 0,45 cm\u207b\u00b9 entre 975 et 980 nm.<\/p>\n\n\n\n Cette diff\u00e9rence a une cons\u00e9quence pratique imm\u00e9diate.<\/p>\n\n\n\n Un traitement \u00e0 1 470 nm ne doit pas \u00eatre d\u00e9crit simplement comme une longueur d'onde \u201c plus profonde \u201d.<\/p>\n\n\n\n Une forte absorption d'eau signifie que l'\u00e9nergie peut \u00eatre d\u00e9pos\u00e9e plus facilement dans les tissus riches en eau, mais cela signifie \u00e9galement que la profondeur de p\u00e9n\u00e9tration optique peut \u00eatre plus courte.<\/p>\n\n\n Il s'agit l\u00e0 d'une contradiction technique importante.<\/p>\n\n\n\n Une longueur d'onde peut avoir une interaction plus forte avec les tissus tout en p\u00e9n\u00e9trant moins profond\u00e9ment<\/strong>.<\/p>\n\n\n\n Cela peut s'av\u00e9rer utile pour un clinicien amen\u00e9 \u00e0 traiter un \u0153d\u00e8me synovial ou un milieu inflammatoire riche en eau. Cependant, cela n\u00e9cessite un dosage contr\u00f4l\u00e9, car la m\u00eame caract\u00e9ristique d'absorption qui rend la longueur d'onde de 1 470 nm int\u00e9ressante sur le plan biologique peut \u00e9galement accro\u00eetre l'accumulation thermique locale.<\/p>\n\n\n\n C'est l\u00e0 que la puissance, le mouvement, la structure d'impulsion, la zone de traitement et le cycle de service deviennent indissociables du choix de la longueur d'onde.<\/p>\n\n\n\n \u00c0 environ 980 nm, l'absorption de l'eau est nettement inf\u00e9rieure \u00e0 celle observ\u00e9e \u00e0 1 470 nm, tandis que l'absorption de l'h\u00e9moglobine reste significative.<\/p>\n\n\n\n La relation entre ces chromophores a \u00e9t\u00e9 largement d\u00e9crite dans la litt\u00e9rature consacr\u00e9e aux lasers m\u00e9dicaux. Les \u00e9tudes comparant les longueurs d'onde utilis\u00e9es pour le traitement des tissus distinguent les longueurs d'onde plus courtes du proche infrarouge, telles que 810, 940, 980 et 1 064 nm, des longueurs d'onde plus longues, sup\u00e9rieures \u00e0 environ 1 200 nm, pour lesquelles l'eau devient un absorbeur beaucoup plus dominant.<\/p>\n\n\n\n Cela conf\u00e8re \u00e0 la longueur d'onde de 980 nm un profil de traitement diff\u00e9rent.<\/p>\n\n\n\n Dans le cadre d'un protocole de r\u00e9\u00e9ducation en profondeur, le praticien peut recourir \u00e0 la longueur d'onde de 980 nm lorsque l'objectif consiste \u00e0 obtenir une p\u00e9n\u00e9tration optique plus profonde associ\u00e9e \u00e0 une interaction vasculaire et photothermique, tandis qu'il privil\u00e9giera la longueur d'onde de 1 470 nm lorsque l'absorption plus importante de l'eau s'av\u00e8re cliniquement utile.<\/p>\n\n\n\n C'est pourquoi un syst\u00e8me de classe IV multi-longueurs d'onde peut s'av\u00e9rer plus pratique qu'une plateforme articul\u00e9e autour d'une seule longueur d'onde fixe.<\/p>\n\n\n\n Le traitement ne doit pas n\u00e9cessairement imposer la m\u00eame strat\u00e9gie optique \u00e0 tous les patients.<\/p>\n\n\n\n Un cas clinique publi\u00e9 par le fabricant FotonMedix d\u00e9crit une patiente \u00e2g\u00e9e de 62 ans pr\u00e9sentant une arthrose bilat\u00e9rale du genou de grade III selon l'\u00e9chelle de Kellgren-Lawrence.<\/p>\n\n\n\n \u00c0 l'inclusion, le patient pr\u00e9sentait une douleur \u00e9valu\u00e9e \u00e0 8\/10 sur l'\u00e9chelle EVA, une flexion du genou limit\u00e9e \u00e0 95 degr\u00e9s et un \u00e9panchement articulaire visible. Les ant\u00e9c\u00e9dents m\u00e9dicaux faisaient \u00e9tat de deux ans de traitement par AINS et d'injections d'acide hyaluronique infructueuses.<\/p>\n\n\n\n C'est pr\u00e9cis\u00e9ment le genre de patient qui met en \u00e9vidence les limites d'un protocole laser trop simpliste.<\/p>\n\n\n\n Le probl\u00e8me ne se limite pas \u00e0 une simple douleur cutan\u00e9e.<\/p>\n\n\n\n Le praticien est confront\u00e9 \u00e0 une articulation atteinte de d\u00e9g\u00e9n\u00e9rescence structurelle, \u00e0 une inflammation, \u00e0 une accumulation de liquide, \u00e0 une limitation de la mobilit\u00e9 et \u00e0 une zone \u00e0 traiter situ\u00e9e sous plusieurs centim\u00e8tres de tissus.<\/p>\n\n\n\n Augmenter la puissance de mani\u00e8re continue poserait un probl\u00e8me \u00e9vident.<\/p>\n\n\n\n La surface se r\u00e9chauffe plus vite.<\/p>\n\n\n\n Cela ne signifie pas pour autant que l\u2019articulation profonde b\u00e9n\u00e9ficie automatiquement d\u2019une exposition th\u00e9rapeutique proportionnellement plus \u00e9lev\u00e9e.<\/p>\n\n\n\n Le protocole publi\u00e9 a donc \u00e9volu\u00e9 au cours des six semaines, au lieu de conserver un seul param\u00e8tre pendant toute la dur\u00e9e du programme.<\/p>\n\n\n\n Le tableau ci-dessous reprend l'\u00e9volution du traitement telle que rapport\u00e9e par FotonMedix pour ce cas publi\u00e9 par le fabricant. Le num\u00e9ro d'identification du cas indiqu\u00e9 ci-dessous est une r\u00e9f\u00e9rence interne simul\u00e9e utilis\u00e9e par le service \u00e0 des fins de r\u00e9f\u00e9rencement naturel (SEO) et d'organisation des cas ; il s'agit de ce n'est pas un num\u00e9ro de dossier hospitalier<\/strong>.<\/p>\n\n\n\n La courbe de progression est techniquement plus int\u00e9ressante que la puissance maximale de 28 W.<\/p>\n\n\n\n Le praticien a augment\u00e9 la puissance au milieu de la cure, puis l'a r\u00e9duite \u00e0 nouveau au cours de la derni\u00e8re semaine.<\/p>\n\n\n\n C'est ainsi qu'il convient de comprendre un protocole th\u00e9rapeutique pratique \u00e0 haute intensit\u00e9.<\/p>\n\n\n\n L'objectif n'est pas d'atteindre la puissance maximale et de s'y maintenir.<\/p>\n\n\n\n L'objectif \u00e9volue en fonction de l'\u00e9volution de l'\u00e9tat clinique du patient.<\/p>\n\n\n\n \u00c0 la fin de la deuxi\u00e8me semaine, le rapport du fabricant faisait \u00e9tat d'une r\u00e9duction significative de l'\u00e9panchement palpable. L'intensit\u00e9 de la douleur, \u00e9valu\u00e9e sur l'\u00e9chelle EVA, est pass\u00e9e de 8\/10 \u00e0 5\/10, et le patient a indiqu\u00e9 pouvoir dormir toute la nuit sans prendre d'analg\u00e9siques.<\/p>\n\n\n\n \u00c0 la quatri\u00e8me semaine, l'amplitude de flexion du genou serait pass\u00e9e de 95 degr\u00e9s \u00e0 125 degr\u00e9s. Le patient \u00e9tait capable de monter les escaliers sans aide.<\/p>\n\n\n\n \u00c0 la 6e semaine, la douleur \u00e9valu\u00e9e selon l'\u00e9chelle VAS \u00e9tait de 1\/10. L'imagerie de suivi a montr\u00e9 une diminution de l'\u00e9paississement synovial et une apparence plus homog\u00e8ne du liquide synovial, tandis que le patient a repris un programme de marche \u00e0 faible impact.<\/p>\n\n\n\n Ces r\u00e9sultats ne doivent pas \u00eatre interpr\u00e9t\u00e9s comme une garantie pour tous les patients atteints d'arthrose de stade III.<\/p>\n\n\n\n Il s'agit d'un rapport clinique publi\u00e9 par le fabricant et non d'un essai contr\u00f4l\u00e9 randomis\u00e9.<\/p>\n\n\n\n La litt\u00e9rature clinique au sens large se montre plus prudente. Une revue syst\u00e9matique et une m\u00e9ta-analyse d'essais randomis\u00e9s ont montr\u00e9 que la th\u00e9rapie au laser \u00e0 haute intensit\u00e9 pouvait r\u00e9duire la douleur et am\u00e9liorer la raideur et la fonction articulaire dans l'arthrose du genou, mais les auteurs ont \u00e9galement soulign\u00e9 le nombre limit\u00e9 et la qualit\u00e9 insuffisante des \u00e9tudes disponibles et ont appel\u00e9 \u00e0 la r\u00e9alisation d'essais de plus grande envergure et mieux con\u00e7us.<\/p>\n\n\n\n C'est une mani\u00e8re bien plus efficace de pr\u00e9senter cette technologie \u00e0 un acheteur professionnel.<\/p>\n\n\n\n The case demonstrates a treatment strategy.<\/p>\n\n\n\n The clinical literature provides a broader evidence context.<\/p>\n\n\n\n Neither should be turned into a universal promise.<\/p>\n\n\n\n The first week used an 80% 980 nm and 20% 1470 nm ratio.<\/p>\n\n\n\n This is not a random combination.<\/p>\n\n\n\n At the beginning of treatment, the clinician has to deal with a painful, reactive joint. A lower total energy and relatively conservative duty cycle allow the operator to establish patient tolerance before progressively increasing the treatment load.<\/p>\n\n\n\n The second week increased the 1470 nm component to 30%.<\/p>\n\n\n\n This matters because 1470 nm has much stronger water absorption.<\/p>\n\n\n\n If the clinical target includes joint effusion or water-rich inflammatory tissue, increasing the contribution of this wavelength changes the distribution of absorbed energy.<\/p>\n\n\n\n The third and fourth weeks moved toward a more balanced combination.<\/p>\n\n\n\n At Week 4, the protocol reached 28 W with a 50% duty cycle and a 50:50 wavelength ratio.<\/p>\n\n\n\n This represents the highest power stage in the published protocol.<\/p>\n\n\n\n The fifth week then shifted further toward 1470 nm while reducing peak power to 25 W.<\/p>\n\n\n\n The sixth week used only 12 W but a 70% 1470 nm ratio in continuous-wave operation.<\/p>\n\n\n\n The sequence demonstrates an important principle.<\/p>\n\n\n\n Power and wavelength ratio should not be treated as independent settings.<\/strong><\/p>\n\n\n\n Changing one changes the thermal and optical environment created by the other.<\/p>\n\n\n\n At first glance, a 100% duty cycle may appear to contradict the idea of thermal management.<\/p>\n\n\n\n It does not necessarily.<\/p>\n\n\n\n Thermal risk depends on much more than duty cycle.<\/p>\n\n\n\n At Week 6, the published protocol reduced peak power to 12 W while using continuous-wave delivery. That is a very different thermal situation from applying 28 W continuously.<\/p>\n\n\n\n The average energy delivery rate is lower.<\/p>\n\n\n\n The tissue is also no longer being exposed to the same treatment objective as during the higher-energy middle phase.<\/p>\n\n\n\n This is an important lesson for anyone comparing a class 4 laser therapy machine for sale.<\/p>\n\n\n\n A machine capable of 30 W or 38 W does not need to operate at its maximum output during every treatment.<\/p>\n\n\n\n The value of the higher output is that the operator has a broader working range.<\/p>\n\n\n\n Duty cycle becomes especially important when the treatment head is close to sensitive superficial tissue.<\/p>\n\n\n\n Suppose a clinician applies high peak power continuously to one relatively small region.<\/p>\n\n\n\n The surface temperature can rise rapidly.<\/p>\n\n\n\n The patient complains.<\/p>\n\n\n\n The clinician stops.<\/p>\n\n\n\n The treatment session ends before enough energy has been delivered to the deeper target.<\/p>\n\n\n\n This is an efficiency problem.<\/p>\n\n\n\n Pulsed delivery changes the time structure.<\/p>\n\n\n\n The system can reach a high instantaneous output during the emission phase while allowing intervals for partial thermal dissipation during the off phase.<\/p>\n\n\n\n The average thermal load can therefore be lower than the peak optical output might suggest.<\/p>\n\n\n\n FotonMedix’s veterinary and equine systems make this concept explicit. VetMedix-MAX lists 38 W peak power, Super Pulse operation, adjustable thermal sensation, and temperature indication.<\/p>\n\n\n\n Theralux-Max lists Super Pulse, Pulse, and CW modes, with the company describing pulsed emission as a way to reduce overheating while continuous emission is positioned for large animals or situations requiring high energy over a short period.<\/p>\n\n\n\n The same physical principle matters in human rehabilitation.<\/p>\n\n\n\n Imagine a treatment target located 5 cm below the skin.<\/p>\n\n\n\n The operator cannot simply assume that the target receives the same optical energy displayed by the machine.<\/p>\n\n\n\n The beam has already encountered:<\/p>\n\n\n\n The deeper target therefore sees a transformed optical field.<\/p>\n\n\n\n This is why \u201cpenetration depth\u201d should be treated carefully in commercial specifications.<\/p>\n\n\n\n A stated 15 cm penetration capability does not mean that 15 cm below the skin receives the same energy density as the surface.<\/p>\n\n\n\n It means the system is designed to maintain useful treatment reach into deeper tissue.<\/p>\n\n\n\n For a B2B buyer, that distinction is important.<\/p>\n\n\n\n It prevents the machine from being evaluated using an unrealistic interpretation of penetration depth.<\/p>\n\n\n\n A procurement manager may compare two machines.<\/p>\n\n\n\n Machine A claims 30 W.<\/p>\n\n\n\n Machine B claims 30 W.<\/p>\n\n\n\n On paper they appear identical.<\/p>\n\n\n\n In practice they may be very different.<\/p>\n\n\n\n The buyer should ask:<\/p>\n\n\n\n Can the system control wavelength selection?<\/p>\n\n\n\n Can it combine wavelengths?<\/p>\n\n\n\n Can it vary pulse frequency?<\/p>\n\n\n\n Can it adjust duty cycle?<\/p>\n\n\n\n Can the operator monitor treatment temperature?<\/p>\n\n\n\n Can the handpiece be used for broad scanning?<\/p>\n\n\n\n Can the machine maintain treatment output as the operator changes treatment modes?<\/p>\n\n\n\n Can the treatment protocol be reproduced consistently?<\/p>\n\n\n\n LaserMedix-MAX lists five wavelengths, 30 W output, peak penetration depth maintaining technology, temperature indication, and dual hot and cold functions.<\/p>\n\n\n\n These functions influence the clinical workflow much more than a single maximum-power number.<\/p>\n\n\n\n A clinic rarely treats one condition.<\/p>\n\n\n\n The same rehabilitation department may see:<\/p>\n\n\n\n The optical target changes from case to case.<\/p>\n\n\n\n A tendon is not a joint capsule.<\/p>\n\n\n\n A muscle is not a synovial cavity.<\/p>\n\n\n\n A superficial wound is not the same target as a deep hip structure.<\/p>\n\n\n\n That is why a multi-wavelength platform can make more sense commercially than a machine optimized for one treatment scenario.<\/p>\n\n\n\n The LaserMedix-MAX configuration combines five wavelengths from 650 nm through 980 nm and is marketed for pain relief, inflammation management, circulation, tissue repair, wound healing, and motor-function improvement.<\/p>\n\n\n\n The operator can therefore build different protocols rather than purchasing a machine that fits only one department’s treatment style.<\/p>\n\n\n\n The clinical logic becomes even more obvious when the target animal is larger.<\/p>\n\n\n\n A deep joint in a large dog or horse may be separated from the skin by substantially more tissue than a superficial human treatment target.<\/p>\n\n\n\n VetMedix-MAX uses the same five-wavelength family of 650 nm, 810 nm, 915 nm, 940 nm, and 980 nm while increasing peak output to 38 W. The platform also includes Super Pulse, thermal indication, dual hot and cold functions, and a claimed 15 cm penetration depth.<\/p>\n\n\n\n The equine Theralux-Max similarly uses five wavelengths and 38 W peak power, with separate Super Pulse, Pulse, and CW modes. The manufacturer positions it for muscle, bone, fascia, joint injuries, pain, fatigue recovery, and microtrauma prevention and repair.<\/p>\n\n\n\n This is useful for distributors because it shows that high-intensity laser technology can be configured around different clinical environments without changing the underlying treatment logic.<\/p>\n\n\n\n FotonMedix’s SurgMedix-MAX uses 1470 nm at up to 20 W, 980 nm at up to 40 W, and 635 nm at 0.5 W. The system is positioned for surgical applications including EVLT, proctology, urology, gynecology, arthroscopy, neurology, ENT, LITT, dermatology, dentistry, and general surgery.<\/p>\n\n\n\n This is not the same clinical application as non-invasive rehabilitation.<\/p>\n\n\n\n The distinction matters.<\/p>\n\n\n\n In surgery, the clinician intentionally uses wavelength-dependent tissue absorption to achieve cutting, coagulation, evaporation, or excision.<\/p>\n\n\n\n In rehabilitation, the goal is different.<\/p>\n\n\n\n The operator is trying to deliver high-energy optical stimulation without producing uncontrolled tissue injury.<\/p>\n\n\n\n The same wavelength physics can therefore produce very different clinical outcomes depending on power, exposure time, treatment geometry, tissue contact, and delivery method.<\/p>\n\n\n\n This is exactly why B2B buyers should not compare therapeutic and surgical laser systems purely by wavelength.<\/p>\n\n\n\n The broader evidence base supports cautious optimism rather than exaggerated claims.<\/p>\n\n\n\n A 2020 systematic review and meta-analysis of randomized controlled trials in knee osteoarthritis included six trials and found that high-intensity laser therapy significantly reduced pain compared with controls, with improvements also reported for stiffness and function. The authors nevertheless concluded that larger and better-designed randomized studies were still needed.<\/p>\n\n\n\n A 2022 systematic review and network meta-analysis examined HILT against other physical therapy modalities in knee osteoarthritis. It found HILT ranked favorably for pain and self-reported function, while the improvement in stiffness was statistically significant but smaller than the minimal clinically important difference.<\/p>\n\n\n\n A later systematic review with meta-analysis published in Th\u00e9rapie physique<\/em> also examined photobiomodulation for knee osteoarthritis and highlighted the importance of separating statistically significant changes from effects that are clinically meaningful to the patient.<\/p>\n\n\n\n That distinction is critical for medical marketing.<\/p>\n\n\n\n A reduction in pain score is useful.<\/p>\n\n\n\n An increase in knee flexion is useful.<\/p>\n\n\n\n Being able to climb stairs without support is more meaningful.<\/p>\n\n\n\n Returning to walking is more meaningful.<\/p>\n\n\n\n Returning to work or sport is even more meaningful.<\/p>\n\n\n\n A professional laser treatment therapy program should therefore measure functional outcomes, not only whether the patient reports feeling warm.<\/p>\n\n\n\n The technical discussion eventually comes back to something very ordinary.<\/p>\n\n\n\n The patient wants to know whether the knee will hurt less.<\/p>\n\n\n\n She wants to bend it further.<\/p>\n\n\n\n She wants to climb stairs.<\/p>\n\n\n\n She wants to sleep without waking because of pain.<\/p>\n\n\n\n She wants to walk without planning every movement around the painful joint.<\/p>\n\n\n\n The machine does not achieve those outcomes simply because it has a high wattage rating.<\/p>\n\n\n\n The treatment must be delivered in a way that the patient can tolerate repeatedly.<\/p>\n\n\n\n That is why thermal sensation is not an incidental detail.<\/p>\n\n\n\n If the treatment becomes uncomfortably hot after two minutes, the clinician has to reduce the exposure.<\/p>\n\n\n\n If the patient can tolerate a controlled warming sensation while the handpiece is moved across the treatment area, a longer and more consistent protocol becomes possible.<\/p>\n\n\n\n Temperature indication therefore has practical value.<\/p>\n\n\n\n LaserMedix-MAX specifically lists Therapeutic Temperature Indication Technology among its features.<\/p>\n\n\n\n High-intensity laser should not be marketed as a replacement for every conventional treatment.<\/p>\n\n\n\n A patient with severe structural osteoarthritis still requires orthopedic assessment.<\/p>\n\n\n\n A tendon rupture still requires appropriate diagnostic imaging and clinical management.<\/p>\n\n\n\n A neurological disorder still requires neurological evaluation.<\/p>\n\n\n\n Exercise remains important.<\/p>\n\n\n\n Strengthening remains important.<\/p>\n\n\n\n Mobility training remains important.<\/p>\n\n\n\n Weight management may be important.<\/p>\n\n\n\n Medication may be appropriate.<\/p>\n\n\n\n Surgery may still be necessary in advanced cases.<\/p>\n\n\n\n The practical role of laser is different.<\/p>\n\n\n\n It can become an additional physical modality within the rehabilitation pathway.<\/p>\n\n\n\n If pain limits exercise, the clinician may use laser as part of a strategy intended to improve treatment tolerance.<\/p>\n\n\n\n If swelling restricts movement, the protocol may prioritize a different wavelength balance.<\/p>\n\n\n\n If the patient is progressing into functional rehabilitation, the clinician can modify the treatment load rather than maintaining the initial settings.<\/p>\n\n\n\n That is where laser becomes useful in real clinical workflow.<\/p>\n\n\n\n A serious B2B purchasing decision should begin with clinical requirements.<\/p>\n\n\n\n Ask which wavelengths are available and what optical interaction each wavelength is intended to provide.<\/p>\n\n\n\n Do not focus only on maximum output.<\/p>\n\n\n\n A broad and controllable operating range is more useful than a machine that is effectively locked into one high-output mode.<\/p>\n\n\n\n Check available frequencies and whether pulsed operation can be adjusted to the treatment objective.<\/p>\n\n\n\n A system should allow the clinician to control emission time relative to rest time when thermal management is important.<\/p>\n\n\n\n A visible temperature reference can help standardize treatment and improve patient comfort.<\/p>\n\n\n\n A deep tissue protocol for the knee is different from a small tendon lesion.<\/p>\n\n\n\n Handpiece geometry and scanning technique therefore matter.<\/p>\n\n\n\n The clinician should be able to save or reproduce treatment settings instead of relying entirely on memory.<\/p>\n\n\n\n For a clinic or distributor, a platform that can serve multiple musculoskeletal indications is generally more commercially useful than a machine built around one narrow application.<\/p>\n\n\n\n The 62-year-old knee case demonstrates a point that is often lost in product marketing.<\/p>\n\n\n\n The treatment did not improve because the clinician simply used the highest available power.<\/p>\n\n\n\n The protocol moved from 15 W in Week 1 to 28 W in Week 4 and then dropped to 12 W in Week 6.<\/p>\n\n\n\n The wavelength balance changed from 80% 980 nm and 20% 1470 nm to 30% 980 nm and 70% 1470 nm.<\/p>\n\n\n\n The duty cycle moved from 30% to 60%, followed by continuous-wave treatment at a much lower power.<\/p>\n\n\n\n The total energy changed from 3,000 J to 7,200 J and then fell to 4,000 J.<\/p>\n\n\n\n Every parameter was part of the treatment strategy.<\/p>\n\n\n\n That is the real difference between operating a high-intensity laser and simply operating a powerful light source.<\/p>\n\n\n\n The difficult part of deep tissue laser therapy is not generating heat.<\/p>\n\n\n\n The difficult part is controlling the relationship between optical penetration, tissue absorption, surface temperature, total energy, and biological response.<\/p>\n\n\n\n 1470 nm provides strong interaction with water-rich tissue, which can be useful but also requires careful thermal control.<\/p>\n\n\n\n 980 nm has a different absorption profile and can provide a useful combination of deeper delivery and interaction with blood-related chromophores.<\/p>\n\n\n\n High peak power provides treatment headroom when photons are lost through scattering and absorption.<\/p>\n\n\n\n Pulse frequency and duty cycle allow that energy to be delivered over time rather than forcing the entire treatment into continuous heating.<\/p>\n\n\n\n Temperature monitoring gives the clinician a practical reference during treatment.<\/p>\n\n\n\n And most importantly, the protocol can change as the patient changes.<\/p>\n\n\n\n That is why a modern laser treatment therapy system should be judged by more than its maximum wattage.<\/p>\n\n\n\n The published six-week case of a 62-year-old woman with Grade III bilateral knee osteoarthritis reported a reduction in VAS pain from 8\/10 to 1\/10, an improvement in knee flexion from 95\u00b0 to 125\u00b0, improved stair climbing, reduced synovial thickening, and a return to low-impact walking. Those results belong to one manufacturer-published case and should not be treated as a universal outcome, but the treatment progression provides a useful example of how wavelength, power, frequency, duty cycle, and total energy can be deliberately changed throughout a rehabilitation course.<\/p>\n\n\n\n For a clinic evaluating a machine de th\u00e9rapie laser de classe 4 \u00e0 vendre<\/strong>, the most important question is therefore not \u201cHow powerful is it?\u201d<\/p>\n\n\n\n A better question is:<\/p>\n\n\n\n Can the system give the clinician enough control to deliver the right amount of energy to the right tissue at the right stage of treatment without making superficial heat the limiting factor?<\/strong><\/p>\n\n\n\n That is where high-intensity laser becomes clinically interesting.<\/p>\n\n\n\n Traditional passive modalities can provide useful symptom management, but they do not give the clinician the same combination of wavelength selection, temporal control, power adjustment, and cumulative optical energy.<\/p>\n\n\n\n A properly planned Class IV protocol does not replace rehabilitation.<\/p>\n\n\n\n It gives rehabilitation another tool.<\/p>\n\n\n\n And when the clinical problem is deep, persistent, and difficult to reach without excessive surface heating, that additional control can make a meaningful difference to how the treatment is delivered.<\/p>","protected":false},"excerpt":{"rendered":" Controlled photon penetration, wavelength-selective absorption, duty-cycle thermal management. A 62-year-old woman arrives at the rehabilitation clinic with a problem that sounds simple but is surprisingly difficult to treat. Her knee hurts every time she climbs stairs. Flexion stops at about 95 degrees. The joint is visibly swollen, and conventional treatment has already consumed months without […]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"themepark_post_bcolor":"#f5f5f5","themepark_post_width":"1022px","themepark_post_img":"","themepark_post_img_po":"left","themepark_post_img_re":false,"themepark_post_img_cover":false,"themepark_post_img_fixed":false,"themepark_post_hide_title":false,"themepark_post_main_b":"","themepark_post_main_p":100,"themepark_paddingblock":false,"slim_seo":{"title":"Title When High Power Heats the Knee Before It Reaches the Target","description":"Description A Grade III knee case shows how 980nm, 1470nm, power and duty cycle can improve deep tissue laser therapy without relying on excessive surface heat."},"footnotes":""},"categories":[19],"tags":[827,815,832,864,817],"class_list":["post-17208","post","type-post","status-publish","format-standard","hentry","category-industry-news","tag-surgical-laser","tag-laser-therapy-machine","tag-deep-tissue-laser-therapy","tag-laser-therapy-machine-for-sale","tag-class-4-laser-therapy"],"metadata":{"_edit_lock":["1787043967:1"],"wpil_sync_report3":["1"],"_edit_last":["1"],"_aioseo_title":[null],"_aioseo_description":[null],"_aioseo_og_title":[""],"_aioseo_og_description":[""],"_aioseo_og_article_section":[""],"_aioseo_twitter_title":[""],"_aioseo_twitter_description":[""],"_aioseo_keywords":["a:0:{}"],"_aioseo_og_article_tags":["a:0:{}"],"catce":["sidebar-widgets4"],"slim_seo":["a:2:{s:5:\"title\";s:65:\"Title When High Power Heats the Knee Before It Reaches the Target\";s:11:\"description\";s:160:\"Description A Grade III knee case shows how 980nm, 1470nm, power and duty cycle can improve deep tissue laser therapy without relying on excessive surface heat.\";}"],"views":["30"]},"aioseo_notices":[],"aioseo_head":"\n\t\t\n\t\n\t\n\t\n\t\n\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\tPourquoi la longueur d'onde de 1 470 nm modifie la strat\u00e9gie th\u00e9rapeutique<\/h2>\n\n\n\n
![\"Laser](\"https:\/\/fotonmedix.com\/wp-content\/uploads\/2026\/08\/laser-light-therapy67-1.jpg\")
<\/figure>\n<\/div>\n\n\nPourquoi la longueur d'onde de 980 nm se comporte diff\u00e9remment<\/h2>\n\n\n\n
L'affaire qui met en lumi\u00e8re le probl\u00e8me<\/h2>\n\n\n\n
Dossier clinique d\u00e9taill\u00e9<\/h2>\n\n\n\n
\u00c9l\u00e9ment clinique<\/th> Informations sur le cas<\/th><\/tr><\/thead> Num\u00e9ro d'affaire du d\u00e9partement (simul\u00e9)<\/td> FM-ORTHO-KOA-026-062<\/td><\/tr> \u00c2ge du patient<\/td> 62 ans<\/td><\/tr> Le sexe<\/td> Femme<\/td><\/tr> D\u00e9partement<\/td> R\u00e9habilitation orthop\u00e9dique<\/td><\/tr> Diagnostic principal<\/td> Arthrose bilat\u00e9rale du genou de grade III<\/td><\/tr> Classification pathologique<\/td> Kellgren-Lawrence de grade III<\/td><\/tr> Douleur (\u00e9chelle EVA) \u00e0 l'inclusion<\/td> 8\/10<\/td><\/tr> Flexion du genou \u00e0 l'\u00e9tat de repos<\/td> 95\u00b0<\/td><\/tr> Probl\u00e8mes articulaires<\/td> \u00c9panchement articulaire visible<\/td><\/tr> Ant\u00e9c\u00e9dents th\u00e9rapeutiques pertinents<\/td> Environ deux ans de traitement par AINS<\/td><\/tr> Traitement par injection pr\u00e9c\u00e9dent<\/td> Injections d'acide hyaluronique sans soulagement durable<\/td><\/tr> Plateforme de traitement<\/td> Syst\u00e8me laser \u00e0 double longueur d'onde et haute intensit\u00e9<\/td><\/tr> Dur\u00e9e du traitement<\/td> 6 semaines<\/td><\/tr> Longueurs d'onde primaires<\/td> 980 nm et 1 470 nm<\/td><\/tr> Objectif principal du traitement<\/td> Contr\u00f4le de la douleur, prise en charge des \u0153d\u00e8mes, am\u00e9lioration de la mobilit\u00e9, stimulation progressive des tissus<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n Progression des param\u00e8tres sur six semaines<\/h3>\n\n\n\n
Semaine<\/th> 980 nm<\/th> 1470 nm<\/th> Puissance de cr\u00eate<\/th> Fr\u00e9quence<\/th> Cycle de travail<\/th> \u00c9nergie totale par s\u00e9ance<\/th> Objectif clinique<\/th><\/tr><\/thead> 1<\/td> 80%<\/td> 20%<\/td> 15 W<\/td> 10 Hz<\/td> 30%<\/td> 3,000 J<\/td> Phase analg\u00e9sique<\/td><\/tr> 2<\/td> 70%<\/td> 30%<\/td> 20 W<\/td> 20 Hz<\/td> 35%<\/td> 4,200 J<\/td> Phase anti-\u0153d\u00e9mateuse<\/td><\/tr> 3<\/td> 60%<\/td> 40%<\/td> 25 W<\/td> 50 Hz<\/td> 40%<\/td> 5,500 J<\/td> Stimulation tissulaire<\/td><\/tr> 4<\/td> 50%<\/td> 50%<\/td> 28 W<\/td> 100 Hz<\/td> 50%<\/td> 7,200 J<\/td> Phase de r\u00e9novation<\/td><\/tr> 5<\/td> 40%<\/td> 60%<\/td> 25 W<\/td> 20 Hz<\/td> 60%<\/td> 6,500 J<\/td> Phase de r\u00e9paration de la matrice<\/td><\/tr> 6<\/td> 30%<\/td> 70%<\/td> 12 W<\/td> CW<\/td> 100%<\/td> 4,000 J<\/td> Soins apaisants et d'entretien<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n Ce qui s'est pass\u00e9 au cours de ces six semaines<\/h2>\n\n\n\n
Why the Wavelength Ratio Changed Every Week<\/h2>\n\n\n\n
Why Continuous Wave Can Be Appropriate at the End<\/h2>\n\n\n\n
Duty Cycle Is a Thermal Control Tool<\/h2>\n\n\n\n
Photon Attenuation Creates a Treatment Efficiency Problem<\/h2>\n\n\n\n
\n
Why 30 W Is Not the Same as 30 W in Every Machine<\/h2>\n\n\n\n
Why a Multi-Wavelength Platform Is Valuable for Clinics<\/h2>\n\n\n\n
\n
The Same Engineering Principle Extends Into Veterinary Medicine<\/h2>\n\n\n\n
The Surgical 1470 nm Platform Shows the Other Side of the Same Physics<\/h2>\n\n\n\n
What the Research Says About High-Intensity Laser Therapy<\/h2>\n\n\n\n
What the Patient Actually Experiences<\/h2>\n\n\n\n
Why Traditional Treatment Still Has a Place<\/h2>\n\n\n\n
What Buyers Should Look For in a Class 4 Laser Therapy Machine for Sale<\/h2>\n\n\n\n
S\u00e9lection de la longueur d'onde<\/h3>\n\n\n\n
Gamme de puissance<\/h3>\n\n\n\n
Pulse Control<\/h3>\n\n\n\n
Cycle de travail<\/h3>\n\n\n\n
Temperature Monitoring<\/h3>\n\n\n\n
Zone de traitement<\/h3>\n\n\n\n
Treatment Reproducibility<\/h3>\n\n\n\n
Department Versatility<\/h3>\n\n\n\n
The Main Lesson From This Case<\/h2>\n\n\n\n
Final Clinical Perspective<\/h2>\n\n\n\n